Preview

Fine Chemical Technologies

Advanced search

Nanoparticles as a toop for drug delivery

Full Text:

Abstract

Common features of nanoparticles as drug delivery venicles and some nanoformulations under development at the chair of biotechnology are considered

About the Authors

A. P. Kaplun
M.V. Lomonosov Moscow State University of Fine Chemical Technologies, 86, Vernadskogo pr., Moscow 119571
Russian Federation


A. E. Stepanov
M.V. Lomonosov Moscow State University of Fine Chemical Technologies, 86, Vernadskogo pr., Moscow 119571
Russian Federation


V. I. Shvets
M.V. Lomonosov Moscow State University of Fine Chemical Technologies, 86, Vernadskogo pr., Moscow 119571
Russian Federation


References

1. Kayser O., Kiderlen A.F. (2003) Delivery strategies for antiparasitics. // Expert Opin. Investig. Drugs V. 12. P. 1-11

2. Allen T., Cullis P., (2004) Drug delivery systems: entering the mainstream. Science. V. 303 P. 1818-1822

3. Tamilvanan S. (2004) Oil-in-water lipid emulsions: implications for parenteral and ocular delivering systems. Progr. Lipid Res. V. 43. P. 489-533.

4. Duncan R, Vicent M.J., Greco F., Nicholson R.I. (2005) Polymer-drug conjugates: towards a novel approach for the treatment of endrocine-related cancer. Endocr. Relat. Cancer. V. 12 Suppl 1: S189-199.

5. ABRAXANE [prescribing information]. Schaumburg, Ill: Abraxis Oncology, a Division of American Pharmaceutical Partners, Inc; January 2005.

6. Singer J.W., Shaffer S, Baker B, et al. (2005) Paclitaxel poliglumex (XTYOTAX; CT2103): an intracellularly targeted taxane. Anti-Cancer Drugs. V. 16. P. 243-254.

7. Farrell R., Heaney D., Giovannoni G. (2005) Emerging therapies in multiple sclerosis. Expert. Opin. Emerg. Drugs. V. 10(4). P. 797-816.

8. Moghimi S.M., Szebeni J. (2003) Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties. Progr. Lipid Res. V. 42. P. 463–478

9. Iurasov V.V., Podgornyi G.I., Kucherianu V.G., Kudrin V.S., Nikushkin E.V., Zhigal'tsev I.V., Sandalov Iu.G., Kaplun A.P., Shvets V.I., Kryzhanovskii G.N. (1996) The effect of liposomal form of LDopa on the level of dopamine, its metabolites, and phospholipid metabolism in the striatum of mice with experimental parkinsonian syndrome [Article in Russian] Biull. Eksp. Biol. Med. V. 122(12). V. 614-617.

10. Zhigaltsev I.V., Kaplun A.P., Kucheryanu V.G, Kryzhanovsky G.N., Kolomeichuk S.N., Shvets V.I., Yurasov V.V. (2001) Liposomes containing dopamine entrapped in response to transmembrane ammonium sulfate gradient as carrier system for dopamine delivery into the brain of parkinson mice. J. Liposome Res. V.11. N 1. P. 55-71

11. Багров С.Н., Новиков С.В., Каплун А.П., Лозинская О.Л. Препарат для лечения заболеваний и повреждений роговицы Патент РФ, №2172026. 2002

12. Ле Банг Шон, Каплун А.П., Шпилевский А.А., Андия-Правдивый Ю.Э., Алексеева С. Г., Григорьев В.Б., Швец В.И. (1998) Синтез бетулиновой кислоты из бетулина и исследование ее солюбилизации с помощью липосом. Биоорган. химия 1998 Т. 24. № 10. С. 787-793.

13. Сымон А.В., Веселова Н.Н., Каплун А.П., Власенкова Н.К., Федорова Г.А., Лютик А. И., Герасимова Г.К., Швец В.И. Синтез циклопропановых производных бетулиновой и бетулоновой кислот и их противоопухолевая активность. (2005) Биоорган. хим. 2005 Т. 31. С.320-325

14. Koller W.C., Paulson G. (Eds.). Handbook of Parkinson’s Disease. Marcel Dekker, New York. 1990.

15. Кучеряну В.Г., Юрасов В.В., Крыжановский Г.Н., Никушкин Е.В., Жигальцев И.В., Каплун А.П., Швец В.И. (1997) Влияние L-DOPA и его липосомальной формы на развитие паркинсонического синдрома у мышей. Бюллетень эксперим. биол. и медицины. 1997.-Т. 123. N 1. С. 29-33.

16. Yagi K., Naoi M., Sasaci H., Abe H., Konishi H., Arichi S. (1982) Incorporation enzyme into the brain by means of liposomes of novel composition. J. Appl. Biochem. V. 4. P. 121-125.

17. Mori N., Sato T., Kumaschiro H. (1992) Anticonvulsant effect of systemically administered GABAcontaining liposomes in rats induced to seizure by amygdaloid electrical stimulation. J. Lipid Res. V. 2. P. 49-55.

18. Yurasov V.V., Kucheryanu V.G., Kaplun A.P., Zhigaltsev I.V., Nikushkin E.V., Shvets V.I., Kryzhanovsky G.N. (1997) Dopamine encapsulated in liposomes exerts antiparkinsonian effects in 1-methyl-4-phenyl-1,2,3,6-tetrahydro-pyridine-treated mice, Proc. of the 24th Int. Symp. on Controlled Release of Bioactive Materials, Stockholm, Sweden, P. 477-478.

19. Борисова Н. В., Крюков В. И., Каплун А. П., Швец В. И. (1996) Физико-химические свойства боратных производных DOPA, допамина и их липосомальных форм Биоорган. Химия 1998 Т. 24. № 11. С. 856-863.

20. Nichols J.W., Deamer, D.W. (1976) Catecholamine uptake and concentration by liposomes pH gradients. Biochim. Biophys. Acta. V. 455. P. 269–271.

21. Cullis P.R., Hope M.J., Bally M.B., Madden T.D., Mayer L.D.,Fenske D.B. (1997) Influence of pH gradients on the transbilayer transport of drugs, lipids, peptides and metal ions into large unilamellar vesicles. Biochim. Biophys. Acta. V. 1331. P. 187–211.

22. Yurasov V.V., Kucheryanu V.G., Podgorni G.N., Kudrin V.S., Kaplun A.P., Zhigaltsev I.V., Shvets, V.I. (1997) Biochemical Effects of Conventional Liposomes in Mice Brain, Proc. of the 25th Int. Symp. Controlled Release of Bioactive Materials, Las Vegas, USA, P. 394-395.

23. Cornford E. M., Cornford M. E. New systems for delivery of drugs to the brain in neurological disease. Lancet Neurology (2002) V. 1. P. 308–315

24. A New Function for the LDL Receptor: Transcytosis of LDL across the Blood–Brain Barrier. Dehouck B., Fenart L., Dehouck M.-P., Pierce A., Torpier G., Cecchelli R. J. Cell Biol. V. 138. (1997) P. 877–889

25. Anezo C., de Vries A. H., Holtje H.-D., Tielema D. P., Marrink S.-J. Methodological Issues in Lipid Bilayer Simulations. (2003) J. Phys. Chem. B. V. 107, P. 9424-943

26. Marrink S.-J., de Vries A. H., Mark A. E.. Coarse Grained Model for Semiquantitative Lipid Simulations. (2004) J. Phys. Chem. B. V. 108, P. 750-760

27. Larson R.A., Sievers E.L., Stadtmauer E.A., Lowenberg B., Estey E.H., Dombret H., Theobald M., Voliotis D., Bennett J.M., Richie M., Leopold L.H., Berger M.S., Sherman M.L., Loken M.R., van Dongen J.J., Bernstein I.D., Appelbaum F.R. (2005) Final report of the efficacy and safety of gemtuzumab ozogamicin (Mylotarg) in patients with CD33-positive acute myeloid leukemia in first recurrence. Cancer. V. 104(7). P. 1442-1452.

28. Cheung C. Y., Murthy N., Stayton P. S., Hoffman A. S. (2001) A pH-Sensitive Polymer That Enhances Cationic Lipid-Mediated Gene Transfer. Bioconjugate Chem. V. 12, P. 906-910.

29. Masson C., Garinot M., Mignet N., Wetzer B., Mailhe P., Scherman D., Bessodes M. (2004) pH-Sensitive PEG lipids containing orthoester linkers: new potential tools for nonviral gene delivery. J. Contr. Rel. V. 99. P. 423–434


For citation:


Kaplun A.P., Stepanov A.E., Shvets V.I. Nanoparticles as a toop for drug delivery. Fine Chemical Technologies. 2006;1(1):5-13. (In Russ.)

Views: 69


ISSN 2410-6593 (Print)
ISSN 2686-7575 (Online)